Medications for Fallopian Tube Carcinoma

5 results

  • avastin - bevacizumab injection, solution

    (Bevacizumab)
    Genentech, Inc.
    Avastin (bevacizumab) is a VEGF inhibitor used with chemotherapy to treat metastatic colorectal cancer, non-squamous non-small cell lung cancer, metastatic renal cell carcinoma, cervical cancer, ovarian/fallopian tube/peritoneal cancer, and hepatocellular carcinoma. Also indicated for recurrent glioblastoma in adults.
    Medication Details
    Drug Interactions

  • elahere - mirvetuximab soravtansine injection, solution

    (Mirvetuximab Soravtansine)
    Immunogen, Inc.
    ELAHERE treats adults with FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens.
    Medication Details
    Drug Interactions

  • lynparza - olaparib tablet, film coated

    (Olaparib)
    Astrazeneca Pharmaceuticals Lp
    Lynparza is a PARP inhibitor for adults with BRCA- or HRR-mutated cancers. Indicated for maintenance of ovarian cancer, adjuvant and metastatic breast cancer, maintenance of metastatic pancreatic cancer, and metastatic castration-resistant prostate cancer. Patient selection requires an FDA-approved companion diagnostic.
    Medication Details
    Drug Interactions

  • zejula - niraparib tablet, film coated

    (Niraparib)
    Glaxosmithkline Llc
    ZEJULA is a PARP inhibitor for maintenance treatment of adults with advanced or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who responded to platinum-based chemotherapy and have HRD-positive status or germline BRCA mutations.
    Medication Details
    Drug Interactions

  • zirabev - bevacizumab - bvzr injection, solution

    (Bevacizumab-Bvzr)
    Pfizer Laboratories Div Pfizer Inc
    Zirabev treats metastatic colorectal cancer, first-line non-squamous non-small cell lung cancer, recurrent glioblastoma in adults, metastatic renal cell carcinoma, persistent/recurrent/metastatic cervical cancer, and epithelial ovarian, fallopian tube, or primary peritoneal cancer. Used in combination with chemotherapy or as single-agent maintenance.
    Medication Details
    Savings Programs
    1
    Drug Interactions